The insulin syringe approach familiar to semaglutide users applies equally well to b12 injections
Baseline and interval laboratory monitoring should include: fasting glucose and HbA1c (tirzepatide can cause hypoglycemia in non-diabetic subjects if caloric intake drops too low), lipase and amylase (pancreatitis risk with GLP-1 agonists), liver function tests (AST, ALT, bilirubin), and thyroid panel (TSH, free T3, free T4)
[DOI] [PubMed] [Google Scholar] 11.Clinical features of different stage subacute combined degeneration of the spinal cord
While the peptides lack of IGF-1 effects and glucose impact suggests minimal interaction potential, comprehensive medication review remains appropriate, particularly for drugs affecting metabolism or blood glucose
Three points deserve attention first
Am J Pathol (2019) 189(11):225868